ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 990,80
-0,83%
Dow Jones
38 852,86
-0,55%
DAX
18 565,30
-0,64%
Brent Oil
84,715
0,46%
Bitcoin
67 880,86
-0,60%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Gilead Sciences Inc (GILD)

  7. Gilead Sciences Inc (GILD) Actualités

GILD Gilead Sciences Inc

63,88
-0,06 (-0,09%)
Avant marché
Dernière mise à jour : 11:47:07
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gilead Sciences Inc GILD NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,06 -0,09% 63,88 11:47:07
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
63,94
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/5/202414:30BWGilead to Present Latest Research Across Key Liver Disease..
18/5/202414:30BWInvestigational Seladelpar Demonstrates Significant..
14/5/202416:09BWKite Data at EHA 2024 Demonstrate Positive Patient Outcomes..
09/5/202423:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202422:11EDGAR2Form 8-K - Current report
09/5/202422:05BWKite and Arcellx Continue Momentum with Advances in..
09/5/202421:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202421:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202422:58EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202414:30BWGilead and Kite Oncology to Highlight Broad and Diverse..
30/4/202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
26/4/202414:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/4/202413:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/4/202422:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/4/202422:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/3/202413:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/3/202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22/3/202414:18BWGilead Sciences Announces Completion of Acquisition of..
19/3/202400:29BWCenter for Disease Analysis Foundation Announces First Round..
11/3/202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/3/202413:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/3/202422:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/3/202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:35BWNew Real-World Data Further Support the Use of Veklury®..
05/3/202422:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
01/3/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:38EDGAR2Form 144 - Report of proposed sale of securities
27/2/202416:00BWGilead Announces Funding Initiative to Support HIV..
26/2/202422:05BWU.S. FDA Approves Expanded Indication for Gilead’s Biktarvy®..
26/2/202414:30BWGilead to Present Late-Breaking Data and Real-World Evidence..
23/2/202412:09EDGAR2Form SC TO-T - Tender offer statement by Third Party
20/2/202422:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/2/202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
14/2/202423:08EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/2/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:14EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202414:39EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202414:37EDGAR2Form 8-K - Current report
10/2/202400:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202417:00BWGilead Named One of America’s Most JUST Companies by JUST..

Dernières Valeurs Consultées

NASDAQ
GILD
Gilead Sciences
BIT
F39007
Vontobel Financial Produ...
LSE
YV44
Citi Fun 25
EU
CAT31
CA Toulouse 31 CCI
UPBT
PXLKRW
Piction Pixel
BIT
UC5F0E
Unicredit Bank
BOV
C1TV34
Corteva
LSE
DU18
Citi Fun 24
USOTC
SHCHF
Shochiku (PK)
UPBT
BOXXBTC
Blockparty
EU
BLSNT
Ares Lusitani Domestic b...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés